(Q57279485)

1

0 references

author name string

Imma Alonso

2

0 references

Aureli Torné

3

0 references

Roser Esteve

4

0 references

Erika Sierra

5

0 references

Luis M. Puig-Tintoré

The causal relation between human papillomavirus and cervical cancer

7

0 references

language of work or name

English

0 references

publication date

November 2005

0 references

published in

Gynecologic Oncology

0 references

volume

99

0 references

issue

2

0 references

page(s)

313-319

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Contribución de la detección del virus del papiloma humano de alto riesgo al estudio de las lesiones premalignas y malignas del cérvix uterino

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

HPV testing in primary screening of older women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Optimizing the hybrid capture II human papillomavirus test to detect cervical intraepithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Method for testing for human papillomavirus infection in patients with cervical intraepithelial disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Detection of cervical precancer and cancer in a hospital population; benefits of testing for human papillomavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Management of women who test positive for high-risk types of human papillomavirus: the HART study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Natural history of cervicovaginal papillomavirus infection in young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High‐Risk Area for Cervical Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Evaluation of adjunctive HPV testing by Hybrid Capture II®in women with minor cytological abnormalities for the diagnosis of CIN2/3 and cost comparison with colposcopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Human papillomavirus DNA testing for cervical cancer screening in low-resource settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Human papillomavirus detection in cervical intraepithelial neoplasia by the second-generation hybrid capture microplate test, comparing two different cervical specimen collection methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Viral load of human papillomavirus and risk of CIN3 or cervical cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011

Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.011